Current Medical Research and Opinion

Quality of structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association: a 10-year follow-up study
pp. 467-474(8)
Authors: Wong, Ho-lun; Truong, Don; Mahamed, Anisah; Davidian, Christine; Rana, Zeeshan; Einarson, Thomas R.

Closing the osteoporosis management gap in primary care: a secondary prevention of fracture programme
pp. 475-482(8)
Authors: Brankin, Eamonn; Mitchell, Caroline; Munro, Robin

Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation
pp. 483-488(6)
Authors: Hing, Jeremy P.; Piotrovsky, Vladimir; Kimko, Hui; Brashear, H. Robert; Zhao, Qinying

Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysis
pp. 489-494(6)
Authors: Walker, John H.; Buys, Yvonne; Trope, Graham; Vicente, Colin; Einarson, Thomas R.; Covert, David; Iskedjian, Michael

Burden of illness in Italian patients with gastro-oesophageal reflux disease
pp. 495-502(8)
Authors: Pacini, Franco; Calabrese, Carlo; Cipolletta, Livio; Valva, Mario D'Ayala; Russo, Antonio; Savarino, Vincenzo; Vigneri, Sergio

Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study.
pp. 503-508(6)
Authors: Shoji, Nobuyuki; Ogata, Hiroko; Suyama, Hideo; Ishikawa, Hitoshi; Suzuki, Hiromasa; Morita, Tetsuya; Kawai, Hiromi; Nishimoto, Hiroyuki; Nemoto, Tetsu; Shimizu, Kimiya

Management of patients with interstitial cystitis or chronic pelvic pain of bladder origin: a consensus report
pp. 509-516(8)
Authors: Kahn, Bruce S.; Stanford, Edward J.; Mishell, Daniel R.; Rosenberg, Matt T.; Wysocki, Susan

Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib
pp. 517-526(10)
Authors: Lehmann, Reiner; Brzosko, Marek; Kopsa, Petr; Nischik, Ruth; Kreisse, Andreas; Thurston, Helen; Litschig, Stephane; Sloan, Victor S.

Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients
pp. 527-534(8)
Authors: Elsammak, M.; Refai, W.; Elsawaf, A.; Abdel-Fattah, I.; Abd Elatti, E.; Ghazal, A.

The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database
pp. 535-544(10)
Authors: Joish, Vijay N.; Donaldson, Gary; Stockdale, William; Oderda, Gary M.; Crawley, Joseph; Sasane, Rahul; Joshua-Gotlib, Sandra; Brixner, Diana I.

How useful are measures of BMD and bone turnover?
pp. 545-554(10)
Authors: Miller, Paul D.; Hochberg, Marc C.; Wehren, Lois E.; Ross, Philip D.; Wasnich, Richard D.

Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial
pp. 555-564(10)
Authors: Zhu, Baojin; Tunis, Sandra L.; Zhao, Zhongyun; Baker, Robert W.; Lage, Maureen J.; Shi, Lizheng; Tohen, Mauricio

Post-marketing surveillance: a UK/European perspective
pp. 565-570(6)
Author: Gough, Stephen

LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia
pp. 571-578(8)
Authors: Brohet, C.; Banai, S.; Alings, A.M.W.; Massaad, R.; Davies, M.J.; Allen, C.

The high prevalence of inadequate serum vitamin D levels and implications for bone health
pp. 579-586(8)
Author: Reginster, Jean-Yves

Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD)
pp. 587-594(8)
Author: Daheshia, Massoud

Pharmacokinetics of palonosetron in combination with aprepitant in healthy volunteers
pp. 595-602(8)
Authors: Shah, Ajit K.; Hunt, Thomas L.; Gallagher, Susan C.; Cullen, Michael T.

Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study
pp. 603-610(8)
Authors: Archimandritis, Athanasios J.; Nikolopoulou, Vassiliki; Kouklakis, Georgios; Paraskevas, Emanouil; Avgerinos, Alexandros; Tsianos, Epaminontas; Triantafillidis, John K.

Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis
pp. 611-618(8)
Authors: Lieberman, Phil; Kaliner, Michael A.; Wheeler, William J.

Cardiovascular risk factors in primary care: methods and baseline prevalence rates – the DETECT program
pp. 619-630(12)
Authors: Wittchen, H.-U.; Glaesmer, H.; März, W.; Stalla, G.; Lehnert, H.; Zeiher, A.M.; Silber, S.; Koch, U.; Böhler, S.; Pittrow, D.; Ruf, G.

A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK
pp. 631-642(12)
Authors: Wade, Alan G.; Toumi, Idris; Hemels, Michiel E.H.

Erratum
pp. 643-644(2)

Current Medical Research and Opinion Notes for Contributors
pp. i-iv(4)